{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:36:06Z","timestamp":1782311766641,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["NIHR131233"],"award-info":[{"award-number":["NIHR131233"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation) trial assesses the clinical and cost-effectiveness of two biopsy procedures in terms of detection of clinically significant prostate cancer (PCa). This article describes the statistical analysis plan (SAP) for the TRANSLATE randomised controlled trial (RCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods\/design<\/jats:title>\n                    <jats:p>TRANSLATE is a parallel, superiority, multicentre RCT. Biopsy-na\u00efve men aged\u2009\u2265\u200918\u00a0years requiring a prostate biopsy for suspicion of possible PCa are randomised (computer-generated 1:1 allocation ratio) to one of two biopsy procedures: transrectal (TRUS) or local anaesthetic transperineal (LATP) biopsy. The primary outcome is the difference in detection rates of clinically significant PCa (defined as Gleason Grade Group\u2009\u2265\u20092, i.e. any Gleason pattern\u2009\u2265\u20094 disease) between the two biopsy procedures. Secondary outcome measures are th eProBE questionnaire (Perception Part and General Symptoms) and International Index of Erectile Function (IIEF, Domain A) scores, International Prostate Symptom Score (IPSS) values, EQ-5D-5L scores, resource use, infection rates, complications, and serious adverse events. We describe in detail the sample size calculation, statistical models used for the analysis, handling of missing data, and planned sensitivity and subgroup analyses. This SAP was pre-specified, written and submitted without prior knowledge of the trial results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Publication of the TRANSLATE trial SAP aims to increase the transparency of the data analysis and reduce the risk of outcome reporting bias. Any deviations from the current SAP will be described and justified in the final study report and results publication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>International Standard Randomised Controlled Trial Number ISRCTN98159689, registered on 28 January 2021 and registered on the ClinicalTrials.gov (NCT05179694) trials registry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-024-08224-4","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:01:37Z","timestamp":1718312497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-8112","authenticated-orcid":false,"given":"Ioana R.","family":"Marian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ooms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair D.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"5","key":"8224_CR1","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.eururo.2007.08.006","volume":"52","author":"V Scattoni","year":"2007","unstructured":"Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol. 2007;52(5):1309\u201322.","journal-title":"Eur Urol"},{"issue":"23","key":"8224_CR2","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2017.18556","volume":"318","author":"C Gamble","year":"2017","unstructured":"Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dor\u00e9 C, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA - Journal of the American Medical Association. 2017;318(23):2337\u201343.","journal-title":"JAMA - Journal of the American Medical Association"},{"issue":"6","key":"8224_CR3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/bju.15978","volume":"131","author":"RJ Bryant","year":"2023","unstructured":"Bryant RJ, Yamamoto H, Eddy B, Kommu S, Narahari K, Omer A, et al. Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique. BJU Int. 2023;131(6):694\u2013704.","journal-title":"BJU Int."},{"issue":"2","key":"8224_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"8224_CR5","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"8224_CR6","unstructured":"Prostate Cancer Foundation (Institution) IS of UP. Gleason Score and Grade Group. 2014 Available from: https:\/\/www.pcf.org\/about-prostate-cancer\/diagnosis-staging-prostate-cancer\/gleason-score-isup-grade\/\u00a0Cited 2021 Sep 22.\u00a0"},{"issue":"6","key":"8224_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822\u201330.","journal-title":"Urology"},{"issue":"2","key":"8224_CR8","first-page":"S189","volume":"197","author":"MJ Barry","year":"2017","unstructured":"Barry MJ, Fowler FJ, O\u2019leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol. 2017;197(2):S189\u201397.","journal-title":"J Urol"},{"issue":"1","key":"8224_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy (New York). 1996;37(1):53\u201372.","journal-title":"Health Policy (New York)"},{"issue":"10","key":"8224_CR10","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"2","key":"8224_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/1536867X1801800207","volume":"18","author":"M Hern\u00e1ndez-Alava","year":"2018","unstructured":"Hern\u00e1ndez-Alava M, Pudney S. eq5dmap: A command for mapping between EQ-5D-3L and EQ-5D-5L. Stata Journal. 2018;18(2):395\u2013415.","journal-title":"Stata Journal."},{"issue":"3","key":"8224_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41391-021-00352-1","volume":"24","author":"BM Mian","year":"2021","unstructured":"Mian BM, Kaufman RP, Fisher HAG. Rationale and protocol for randomized study of transrectal and transperineal prostate biopsy efficacy and complications (ProBE-PC study). Prostate Cancer Prostatic Dis. 2021;24(3):688\u201396.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"8224_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.juro.2018.09.049","volume":"201","author":"RJ Bryant","year":"2019","unstructured":"Bryant RJ, Hobbs CP, Eyre KS, Davies LC, Sullivan ME, Shields W, et al. Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study. J Urol. 2019;201(3):510\u20139.","journal-title":"J Urol"},{"issue":"8","key":"8224_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2013.879","volume":"309","author":"M Calvert","year":"2013","unstructured":"Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD. Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA - Journal of the American Medical Association. 2013;309(8):814\u201322.","journal-title":"JAMA - Journal of the American Medical Association."},{"issue":"9","key":"8224_CR15","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1177\/0962280216683570","volume":"27","author":"TR Sullivan","year":"2018","unstructured":"Sullivan TR, White IR, Salter AB, Ryan P, Lee KJ. Should multiple imputation be the method of choice for handling missing data in randomized trials? Stat Methods Med Res. 2018;27(9):2610\u201326.","journal-title":"Stat Methods Med Res"},{"key":"8224_CR16","volume-title":"Stata module to analyse a randomised controlled trial (RCT) allowing for informatively missing outcome data. Computer Science Statistical Software Components","author":"I White","year":"2017","unstructured":"White I. Stata module to analyse a randomised controlled trial (RCT) allowing for informatively missing outcome data. Computer Science Statistical Software Components. 2017."},{"issue":"6","key":"8224_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/MOU.0000000000000678","volume":"29","author":"A Omer","year":"2019","unstructured":"Omer A, Lamb AD. Optimizing prostate biopsy techniques. Curr Opin Urol. 2019;29(6):578\u201386.","journal-title":"Curr Opin Urol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08224-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:02:21Z","timestamp":1718312541000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08224-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8224"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08224-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3924145\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The TRANSLATE trial has approval from the Oxford C Research Ethics Committee (REC: 21\/SC\/0271). Informed consent from all study participants was sought and obtained by a research facilitator trained in Good Clinical Practice (GCP). Participant data was only collected after consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}